Back to news

Hovione Capital organizes the largest-ever Healthcare Investor Conference in Portugal

19 . Sep . 2019
Share:
Linkedin

                                                      

Taking place during the Web Summit week, the Lisbon Investor Conference will bring together during two days, investment leaders and entrepreneurs, looking for new opportunities to spark new businesses and grow existing ones. Eleven European VC funds with €6.0 Billion under management will be present at the event.


The second day of the conference, will be dedicated to startups and investors focusing on health care innovation. Over 20 European startups have been selected to present, and jury members from the VC industry will pick the most promising.  Investment in the health care sector has been witnessing a steady growth: in Europe alone, start-ups in this area received a total investment of approximately 4 billion Euros in 2018. This day is being organized by Hovione Capital, a VC company specialized in healthcare investments across Europe:

"11 of the World’s largest healthcare Investors – who have in total funds of almost €6.0 Billion under management – will be present. This is an excellent opportunity for them to find promising startups and spot trends in pharmaceutical innovation. We are also excited to have representatives from the pharmaceutical industry, such as Johnson & Johnson and Merck Sharp & Dohme (MSD)”, said Ricardo Perdigão Henriques, CEO of Hovione Capital and Day Two Conference Chair.


Gala Dinner. 
A gala dinner is also included in the programme. It will take place on November 7th, at the Kais Restaurant in Lisbon and 100-foot wave surfer Garrett McNamara will be the keynote speaker.


To see the full programme please visit Lisbon Investor Conference




Your cookie settings

We ask you to accept cookies for the purpose of performance, social networking and advertising.
For more information or correct your preferences, press the button "more info".
For more information about these cookies and the processing of your personal data, check out our cookie and Privacy Policy. Accept these cookies and the processing of personal data involved?

Accept cookies More information